Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which drainage method is better for polyhydramnios?

NCT ID NCT00236340

Symptom relief Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at two techniques for removing extra amniotic fluid in pregnant women with polyhydramnios (too much fluid). One method uses a syringe to manually pull out fluid, while the other uses a continuous suction machine. Researchers measured pain, fluid volume removed, and safety for mother and baby. The goal is to find which approach works best with the least discomfort.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
amniotic fluid drainage (syringe or continuous suction)
What this could lead to
If successful, this could identify a safer, less painful way to drain excess amniotic fluid during pregnancy.
What could go wrong
This is a small, completed trial with only 80 participants, so results may not apply to all cases. Both methods carry risks like infection or preterm labor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Jan 2002

Finished

Feb 2005

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women with abdomen discumfort and ultrasound diagnosis of polyhydramnios (AFI\>25cm) * Single or twin pregnancies Exclusion Criteria: * Multiple pregnancy (more than 3 fetuses) * Maternal history of placental abruptio * Fetus with IUGR * Pregnancy complicated with pre-eclampsia * Unability to give informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Polyhydramnios are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

polyhydramnios

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Polyhydramnios

Contacts and locations

Locations

  • CHU Bretonneau

    Tours, Centre-Val de Loire, 37000, France